Helius Medical Technologies Inc (NASDAQ:HSDT)’s traded shares stood at 35.43 million during the last session, with the company’s beta value hitting 1.10. At the close of trading, the stock’s price was $0.60, to imply a decrease of -45.89% or -$0.51 in intraday trading. The HSDT share’s 52-week high remains $24.00, putting it -3900.0% down since that peak but still an impressive -25.0% since price per share fell to its 52-week low of $0.75. The company has a valuation of $0.32M, with an average of 24.28 million shares in intraday trading volume over the past 10 days and average of 3.26 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Helius Medical Technologies Inc (HSDT), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give HSDT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
After registering a -45.89% downside in the last session, Helius Medical Technologies Inc (HSDT) has traded red over the past five days. The 5-day price performance for the stock is -47.32%, and -85.93% over 30 days. With these gigs, the year-to-date price performance is -94.03%. Short interest in Helius Medical Technologies Inc (NASDAQ:HSDT) saw shorts transact 62031.0 shares and set a 1.98 days time to cover.
HSDT Dividends
Helius Medical Technologies Inc has its next earnings report out on 2025-Apr-30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Helius Medical Technologies Inc insiders hold 5.75% of total outstanding shares, with institutional holders owning 0.50% of the shares at 0.53% float percentage. In total, 0.50% institutions holds shares in the company.
We also have Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Helius Medical Technologies Inc (HSDT) shares. Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund holds roughly 6.21 shares. This is just over 0.08% of the total shares, with a market valuation of $3729.0. Data from the same date shows that the other fund manager holds a little less at 1.92, or 0.02% of the shares, all valued at about 1152.0.
